Research Paper Volume 15, Issue 8 pp 2937—2969

FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma


Figure 12. The correlation of drug sensitivity and cancer pathway activity about FARSB in HCC patients. (A) FARSB-related cancer pathway activity. (B) FARSB-related drug sensitivity using GDSC.